Emerging in the field of obesity management, retatrutide is a distinct strategy. Unlike many existing medications, retatrutide functions as a dual agonist, concurrently targeting both glucagon-like peptide-1 (GLP-1) https://orlandownsg694845.bloggin-ads.com/61740387/a-novel-retatrutide-this-glp-and-gip-receptor-agonist